(ARGX) Argen-X - Performance 48.6% in 12m
Compare ARGX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
91.03%
#4 in Group
Rel. Strength
90.13%
#755 in Universe
Total Return 12m
48.57%
#25 in Group
Total Return 5y
319.37%
#8 in Group
P/E 46.3
82th Percentile in Group
P/E Forward 89.3
89th Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -0.43%
77th Percentile in Group
12m Total Return: ARGX (48.6%) vs XBI (-11%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
| AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
| LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
| NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
| BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
| KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: ARGX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARGX
| Total Return (including Dividends) | ARGX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -11.10% | -5.85% | -3.01% |
| 3 Months | -12.12% | -11.95% | -3.15% |
| 12 Months | 48.57% | -11.00% | 10.19% |
| 5 Years | 319.37% | 0.65% | 129.24% |
| Trend Score (consistency of price movement) | ARGX | XBI | S&P 500 |
| 1 Month | -18.4% | -59.8% | -5.5% |
| 3 Months | -89.0% | -70.5% | -58.4% |
| 12 Months | 91.6% | -6.9% | 84.1% |
| 5 Years | 91.0% | -50% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #102 | -5.57% | -8.34% |
| 3 Month | #57 | -0.19% | -9.26% |
| 12 Month | #25 | 66.9% | 34.8% |
| 5 Years | #8 | 317% | 82.9% |
FAQs
Does ARGX Argen-X outperforms the market?
Yes,
over the last 12 months ARGX made 48.57%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months ARGX made -12.12%, while XBI made -11.95%.
Over the last 3 months ARGX made -12.12%, while XBI made -11.95%.
Performance Comparison ARGX vs Indeces and Sectors
ARGX vs. Indices ARGX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.93% | -8.09% | 8.20% | 38.4% |
| US NASDAQ 100 | QQQ | 0.05% | -7.04% | 8.97% | 40.0% |
| US Dow Jones Industrial 30 | DIA | -1.13% | -8.96% | 7.28% | 39.1% |
| German DAX 40 | DAX | 0.37% | -7.72% | -8.59% | 26.9% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.64% | -11.3% | 23.4% | 39.5% |
| Hongkong Hang Seng | HSI | -2.90% | -13.9% | 17.4% | 31.2% |
| India NIFTY 50 | INDA | -1.96% | -19.0% | 18.6% | 47.9% |
| Brasil Bovespa | EWZ | -1.04% | -19.4% | 16.2% | 60.3% |
ARGX vs. Sectors ARGX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.61% | -7.29% | 0.09% | 29.4% |
| Consumer Discretionary | XLY | -1.69% | -7.27% | 4.84% | 34.5% |
| Consumer Staples | XLP | -3.72% | -9.26% | 7.36% | 37.5% |
| Energy | XLE | -2.02% | -19.1% | 2.62% | 47.8% |
| Financial | XLF | -1.41% | -8.40% | -3.96% | 26.3% |
| Health Care | XLV | -1.35% | -7.94% | 12.9% | 46.9% |
| Industrial | XLI | -1.24% | -10.4% | 8.91% | 40.0% |
| Materials | XLB | -2.03% | -11.6% | 16.3% | 52.5% |
| Real Estate | XLRE | -2.97% | -8.41% | 11.3% | 35.2% |
| Technology | XLK | 0.20% | -7.09% | 13.3% | 46.6% |
| Utilities | XLU | -4.22% | -11.9% | 9.08% | 23.3% |
| Aerospace & Defense | XAR | -0.33% | -12.4% | 4.28% | 27.6% |
| Biotech | XBI | 3.63% | -5.25% | 25.9% | 59.6% |
| Homebuilder | XHB | -1.43% | -11.3% | 27.6% | 56.3% |
| Retail | XRT | -3.23% | -10.6% | 12.3% | 53.4% |